Lars Åke Martin

Chromafora AB offers water purification and technology for selective heavy metal separation to a global market. It provides chemical reducing technology. Its services include selective metal extraction to handle waste streams containing dissolved heavy metals and chemical synthesis. The company was founded by Martin Kullberg, Karl Gaston Lavén, and Henrik Joachim Rundgren in 2010 and is headquartered in Solna, Sweden.

Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies.

Part of Merck & Co., Inc., Merck Sharp & Dohme (Sweden) AB is a biopharmaceutical company based in Stockholm, Sweden. MSD Sweden is focused on inventing medicines and vaccines to save and improve lives, sharing a vision and mission to achieve this goal. The Swedish company was founded in 1974. The CEO is Björn Fredrik Niklas Andreasson.

OrtoWay AB develops instruments for spinal surgery. It facilitates the deployment of artificial discs. The company was founded in October 2006 and is headquartered in Danderyd, Sweden.

Clinical Data Care AB provided contract research services in the healthcare industry. It was founded to meet the growing needs of the pharmaceutical industry and handles every aspect of clinical trials. Trial Form Support International, TFS, AB has acquired the company in 2005. Clinical Data Care was located in Lund, Sweden.

ONCOlog Medical QA AB develops and markets system solutions for quality assurance of radiotherapy treatment clinics for cancer. Its products include IMRTLog, QAMLog, EcoLog, MachLog, TopLog, ChemoCare, EvidenceLog, and DocLog. The company was founded in 2002 and is headquartered in Uppsala, Sweden.

NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden.